Dubai, United Arabi Emirates: Fincasa Ventures, a UAE Based advisor to Multi-Royal-Family fund Houses has invested 50 million USD into MediSponsor.Inc - a USA incorporated company, which offers easy-to-use XAAS-based innovative yet Integrated Healthcare Cloud CRM Solution along with Payment Gateway.
Along with Fincasa Ventures, Strategic Swiss Partners AG (SSP), a leading boutique management & financial advisory firm based in Zurich, will also be part of this collaboration to enhance business development for MediSponsor.
Varis Sayed, Founder & CEO of Fincasa Ventures said that the “MediSponsor is upcoming player in the start-up industry which will bring value proposition on COVID-19 Pandemic through its Visual Analytics technology as well as impact in healthcare service delivery”
This investment would enable MediSponsor to capitalize and position company in the healthcare sector of Africa, Middle East, South America & South Asia through care model innovation and digital market transformation.
Rahul Pawar, Founder & CEO of MediSponsor said that “Fincasa Ventures investment along with the strategic partnership of SSP will help us scale up and expand in global markets. We at MediSponsor, endeavour to integrate the fragmented global healthcare ecosystem, spread across multiple countries and continents, into a singular digital platform to ensure seamless flow of our bouquet of innovative offerings.
MediSponsor delivers services into three segments – cognitive, care and cure through its proprietary XAAS platform. Through this investment, the company aims to introduce innovative solutions as TraCovid IT Solution (a contact tracing application), Hospital Management Information System, Augmented Glasses with inbuilt thermal and facial recognition system that will not only enhance the healthcare industry in the country, but also serve as a key essential for government organisations and retail sector.
The Head Quarter in Dubai gives the company a world-class business environment for speedy growth. This investment along with strategic partnership will help MediSponsor to achieve its vision of being the most valued brand in Healthcare Technology.
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.